In-Hospital Surgical Site Infections after Primary Hip and Knee Arthroplasty - Incidence and Risk Factors

Journal of Arthroplasty

Volumn 28, Issue 3, 2013, Pages 385-389

  Poultsides, Lazaros A ^a   Ma, Yan ^a   Della Valle, Alejandro Gonzalez ^a   Chiu, Ya Lin ^a   Sculco, Thomas P ^a   Memtsoudis, Stavros G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cost; Infected total hip arthroplasty; Infected total knee arthroplasty; Risk factors; Surgical site infections; Total joint arthroplasty

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CANCER DIAGNOSIS; CHILD; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ELECTROLYTE DISTURBANCE; FEMALE; HEMATOMA; HOSPITAL CARE; HOSPITAL COST; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFANT; LENGTH OF STAY; LIVER CANCER; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; SEROMA; SURGICAL INFECTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; WOUND DEHISCENCE;

ADULT; AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CROSS INFECTION; FEMALE; HOSPITAL COSTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SURGICAL WOUND INFECTION; UNITED STATES;

EID: 84874557915     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2012.06.027     Document Type: Article

References (39)

1. Jones C.A., Beaupre L.A., Johnston D.W., et al. Total joint arthroplasties: current concepts of patient outcomes after surgery. Clin Geriatr Med 2005, 21:527.
2. Bozic K.J., Kurtz S.M., Lau E., et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res 2010, 468:45.
3. Bozic K.J., Kurtz S.M., Lau E., et al. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am 2009, 91:128.
4. Phillips J.E., Crane T.P., Noy M., et al. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br 2006, 88:943.
5. Kurtz S., Ong K., Lau E., et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007, 89:780.
6. Kurtz S., Lau E., Schmier J., et al. Nationwide infection burden in revision hip and knee arthroplasty. Trans Orthop Res Soc 2006, 31:179.
7. Kurtz S.M., Ong K.L., Schmier J., et al. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am 2007, 89(Suppl 3):144.
8. Poultsides L.A., Liaropoulos L.L., Malizos K.N. The socioeconomic impact of musculoskeletal infections. J Bone Joint Surg Am 2010, 92:e13.
9. Maksimovic J., Markovic-Denic L., Bumbasirevic M., et al. Surgical site infections in orthopedic patients: prospective cohort study. Croat Med J 2008, 49:58.
10. Wilson J., Charlett A., Leong G., et al. Rates of surgical site infection after hip replacement as a hospital performance indicator: analysis of data from the English mandatory surveillance system. Infect Control Hosp Epidemiol 2008, 29:219.
11. Berbari E.F., Hanssen A.D., Duffy M.C., et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998, 27:1247.
12. Anonymous HCUP databases. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD, 2008. (Accessed February 15, 2010, at ). http://www.hcup-us.ahrq.gov/nisoverview.jsp.
13. Anonymous publications from the HCUP databases. Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project (HCUP). Rockville, MD, 2008. (Accessed February 15, 2010, at ). http://www.ahrq.gov/data/hcup/hcupref.htm.
14. Memtsoudis S.G., Ma Y., Gonzalez Della Valle A., et al. Perioperative outcomes after unilateral and bilateral total knee arthroplasty. Anesthesiology 2009, 111:1206.
15. Elixhauser A., Steiner C., Harris D.R., et al. Comorbidity measures for use with administrative data. Med Care 1998, 36:8.
16. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45:613.
17. Kozak L.J. Underreporting of race in the national hospital discharge survey. Adv Data 1995, 265:1.
18. Bolon M.K., Hooper D., Stevenson K.B., et al. Improved surveillance for surgical site infections after orthopedic implantation procedures: extending applications for automated data. Clin Infect Dis 2009, 48:1223.
19. Malinzak R.A., Ritter M.A., Berend M.E., et al. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplasty 2009, 24:84.
20. Meding J.B., Reddleman K., Keating M.E., et al. Total knee replacement in patients with diabetes mellitus. Clin Orthop Relat Res 2003, 416:208.
21. Pulido L., Ghanem E., Joshi A., et al. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008, 466:1710.
22. Dowsey M.M., Choong P.F. Obesity is a major risk factor for prosthetic infection after primary hip arthroplasty. Clin Orthop Relat Res 2008, 466:153.
23. Horan F. Obesity and joint replacement. J Bone Joint Surg Br 2006, 88:1269.
24. Krushell R.J., Fingeroth R.J. Primary total knee arthroplasty in morbidly obese patients: a 5- to 14-year follow-up study. J Arthroplasty 2007, 22:77.
25. Moran M., Walmsley P., Gray A., et al. Does body mass index affect the early outcome of primary total hip arthroplasty?. J Arthroplasty 2005, 20:866.
26. Bochicchio G.V., Joshi M., Bochicchio K.M., et al. Early hyperglycemic control is important in critically injured trauma patients. J Trauma 2007, 63:1353.
27. Chiu F.Y., Lin C.F., Chen C.M., et al. Cefuroxime-impregnated cement at primary total knee arthroplasty in diabetes mellitus. A prospective, randomised study. J Bone Joint Surg Br 2001, 83:691.
28. Menon T.J., Thjellesen D., Wroblewski B.M. Charnley low-friction arthroplasty in diabetic patients. J Bone Joint Surg Br 1983, 65:580.
29. Bourne R.B. Prophylactic use of antibiotic bone cement: an emerging standard-in the affirmative. J Arthroplasty 2004, 19:69.
30. Boulton A.J., Armstrong D.G., Albert S.F., et al. Comprehensive foot examination and risk assessment: a report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 2008, 31:1679.
31. Wukich D.K., Lowery N.J., McMillen R.L., et al. Postoperative infection rates in foot and ankle surgery: a comparison of patients with and without diabetes mellitus. J Bone Joint Surg Am 2010, 92:287.
32. Pedersen A.B., Mehnert F., Johnsen S.P., et al. Risk of revision of a total hip replacement in patients with diabetes mellitus: a population-based follow up study. J Bone Joint Surg Br 2010, 92:929.
33. Marchant M.H., Viens N.A., Cook C., et al. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am 2009, 91:1621.
34. Pramoolsinsup C. Management of viral hepatitis B. J Gastroenterol Hepatol 2002, 17(Suppl):S125.
35. Mendenhall C.L., Seeff L., Diehl A.M., et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA cooperative study group (no. 119). Hepatology 1991, 14:581.
36. Rimola A. Infections in liver disease. Oxford textbook of clinical hepatology 1991, 2:1272. Oxford University Press, Oxford, England. N. McIntyre, J.-P. Benhamou, J. Bircher, M. Rizzetto, J. Rodes (Eds.).
37. Gomez F., Ruiz P., Schreiber A.D. Impaired function of macrophage fc gamma receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med 1994, 331:1122.
38. Hsieh P.H., Chen L.H., Lee M.S., et al. Hip arthroplasty in patients with cirrhosis of the liver. J Bone Joint Surg Br 2003, 85:818.
39. Parvizi J., Ghanem E., Joshi A., et al. Does "excessive" anticoagulation predispose to periprosthetic infection?. J Arthroplasty 2007, 22:24.